By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteome Sciences and the Moffitt Cancer Center have struck a partnership to research ways to develop assays that can be adapted for analyzing tumors, the UK-based company said today.

Proteome Sciences said it will work with Moffitt, located in Tampa, Fla., to develop mass spectrometry assays that can measure important signalling and repair pathway proteins for use in tumor biopsy analysis in the clinic.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.